Dr Busch was recently interviewed by IO Learning about integrating the recently FDA-approved TULSA treatment into his practice.
He explained that in the phase 2 trial … “They treated the entire gland with TULSA, and compared it with prostatectomy, with 4-year data now available. First, they’ve shown that they can kill cancer with this technique. Second, and very importantly, they’ve shown that 90% of the men who had sexual function before the procedure retained their sexual function afterward. In addition, 98% of the men who had no urinary incontinence before the procedure maintained bladder control afterward, so the toxicity of the TULSA procedure seems to be less when compared with prostatectomy. The phase 2 trial results were therefore very promising, so the FDA approved the use of TULSA in America. We are one of only two sites in the United States to offer this procedure … We are the first site in the world to do this procedure without general anesthesia, which means no intubation. This was executed by our CRNAs with the use of MAC (managed anesthesia care) and with MPM (multimodal pain management).”
Read the entire interview here.